577 related articles for article (PubMed ID: 31264429)
21. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
22. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
23. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
Mousses S; Kiefer J; Von Hoff D; Trent J
Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
[TBL] [Abstract][Full Text] [Related]
24. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP
Oncotarget; 2016 Aug; 7(35):56491-56500. PubMed ID: 27447854
[TBL] [Abstract][Full Text] [Related]
25. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
26. Precision medicine in pediatric oncology: Lessons learned and next steps.
Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
[TBL] [Abstract][Full Text] [Related]
27. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer.
Bottosso M; Mosele F; Michiels S; Cournède PH; Dogan S; Labaki C; André F
ESMO Open; 2024 Mar; 9(3):102247. PubMed ID: 38401248
[TBL] [Abstract][Full Text] [Related]
28. Progress in precision therapy in pediatric oncology.
O'Donohue T; Farouk Sait S; Glade Bender J
Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
[TBL] [Abstract][Full Text] [Related]
29. Cancer genomics guide clinical practice in personalized medicine.
Lehmann-Che J; Poirot B; Boyer JC; Evrard A
Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
[TBL] [Abstract][Full Text] [Related]
30. Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.
Silvestris N; Ciliberto G; De Paoli P; Apolone G; Lavitrano ML; Pierotti MA; Stanta G;
J Exp Clin Cancer Res; 2017 Sep; 36(1):128. PubMed ID: 28903768
[TBL] [Abstract][Full Text] [Related]
31. Precision oncology in the age of integrative genomics.
Kumar-Sinha C; Chinnaiyan AM
Nat Biotechnol; 2018 Jan; 36(1):46-60. PubMed ID: 29319699
[TBL] [Abstract][Full Text] [Related]
32. Recent Advancements and Innovations in Pediatric Precision Oncology.
Mangum R; Lin FY; Parsons DW
J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
[TBL] [Abstract][Full Text] [Related]
33. Genomics and bioinformatics as pillars of precision medicine in oncology.
Canzoneri R; Lacunza E; Abba MC
Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
[TBL] [Abstract][Full Text] [Related]
34. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
Surrey LF; Luo M; Chang F; Li MM
Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
[TBL] [Abstract][Full Text] [Related]
35. Precision diagnostics in cancer: Predict, prevent, and personalize.
Crabtree JS; Miele L
Prog Mol Biol Transl Sci; 2022; 190(1):39-56. PubMed ID: 36008001
[TBL] [Abstract][Full Text] [Related]
36. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
[TBL] [Abstract][Full Text] [Related]
37. High-throughput sequencing in clinical oncology: from past to present.
Mery B; Vallard A; Rowinski E; Magne N
Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
[TBL] [Abstract][Full Text] [Related]
38. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
39. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.
Piñeiro-Yáñez E; Reboiro-Jato M; Gómez-López G; Perales-Patón J; Troulé K; Rodríguez JM; Tejero H; Shimamura T; López-Casas PP; Carretero J; Valencia A; Hidalgo M; Glez-Peña D; Al-Shahrour F
Genome Med; 2018 May; 10(1):41. PubMed ID: 29848362
[TBL] [Abstract][Full Text] [Related]
40. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]